Educational Activities

In this CME Outfitters recorded webcast, expert faculty will discuss guideline-recommended approaches to the diagnosis and management of retinal disease, explore strategies for developing individualized treatment plans that address patient needs and access barriers, and examine the mechanistic role of blood–retinal barrier dysfunction as the scientific rationale for emerging therapies. The webcast will also feature patient interviews.

In this CMEO BriefCase, expert faculty will walk learners through a real-world case, stopping for strategic discussions on the assessment of data on available anti-CD20 therapies to make appropriate recommendations for patients with MS, utilization of evidence-based guidelines for MS management to optimize treatment selection and monitor therapeutic outcomes, and the development of tailored MS treatment plans to address the unique physiological and social needs of older and pediatric patients.

Culturally respectful care starts at the very beginning of life, shaped by the rich lived experiences, traditions, and values that influence how children and families interact with the healthcare system. Every family brings unique circumstances, and clinicians and multidisciplinary teams must be ready to meet those diverse needs with sensitivity and confidence. By understanding family roles and dynamics, addressing disparities influenced by social drivers of health (SDoH), and partnering with schools and communities, clinicians can create a supportive, trusting environment for this vulnerable patient population. Best-in-class education will empower care teams to deliver compassionate, culturally attuned care that makes a meaningful difference for every child and family they serve.

In this CME Outfitters Snack, part of a series on health equity, expert faculty will address these gaps by identifying the principles of culturally respectful child and adolescent care while modeling care plans that reflect and respect individual family priorities and preferred communication strategies. Faculty will demonstrate the use of comprehensive SDoH screening and management approaches and describe the benefits of closed-loop referrals for addressing identified family needs. Learners will be shown how to integrate system-level, compliant, coordinated workflows with schools and community resources to address the unique health needs of children and adolescents in diverse populations including rural and Indigenous settings.

In this CME Outfitters recorded webcast, expert faculty will explore comorbidities and quality-of-life concerns that impact individuals with LGS and their caregivers. The activity will highlight team-based strategies to support long-term planning and successful transitions from pediatric to adult care.

Generalized myasthenia gravis (gMG) disrupts neuromuscular transmission, creating unpredictable symptom flare-ups and placing a significant burden on patients with this rare condition. Most commonly associated with antibodies targeting the acetylcholine receptor (AChR), and less commonly with muscle specific kinase (MuSK) or low-density lipoprotein receptor–related protein 4 (LRP4), gMG has forced patients and clinicians to navigate treatments that can be difficult to tolerate, slow to act, or limited by safety concerns. The expanding availability of neonatal Fc receptor (FcRn) blockers has introduced targeted options designed to reduce pathogenic IgG and improve symptoms. Clinicians, however, lack practical, evidence-based guidance on optimizing FcRn antagonist regimens in partial responders, including interval adjustments, transitions between cyclic and consistent dosing, structured monitoring, and safe steroid tapering, which results in persistent symptoms and avoidable treatment burden. Clinicians and multidisciplinary care teams require rigorous education in optimized dosing and longitudinal management to transform the care experience for patients with gMG.

In the second activity of this CME Outfitters BriefCase series, expert faculty will differentiate MOAs, safety, and efficacy profiles of currently approved FcRn antagonists for the treatment of gMG. Faculty will incorporate strategies to identify patients with gMG who may be appropriate candidates for treatment with FcRn antagonists, and utilize an individualized approach to treatment planning for patients with gMG receiving FcRn antagonists based on the latest data as well as patient preferences.

In the first activity of this CME Outfitters BriefCase series, expert faculty will differentiate MOAs, safety considerations, and efficacy data of currently approved FcRn antagonists for the treatment of gMG. Faculty will incorporate strategies to identify patients with gMG who may be appropriate candidates for FcRn antagonist therapy, and apply an individualized approach to treatment planning based on available evidence and patient preferences.